LONG TERM EFFICACY OF INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE AT A SINGLE TERTIARY CENTER

被引：0
|
作者：
Nuti, F. [1 ]
Conte, F. [1 ]
Cavallari, N. [1 ]
Civitelli, F. [1 ]
Aloi, M. [1 ]
Del Giudice, E. [1 ]
Pannone, V. [1 ]
Di Nardo, G. [1 ]
Cucchiara, S. [1 ]
Viola, F. [1 ]
机构：
[1] Univ Roma La Sapienza, Pediat Gastroenterol & Liver Unit, Rome, Italy
来源：
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION | 2010年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E108 / E108
页数：1
相关论文
共 50 条
  • [31] Long-Term Efficacy of Vedolizumab in Pediatric Inflammatory Bowel Disease
    Sarles, Harry E., Jr.
    Whitney, Annette E.
    Kuten, Samantha A.
    Van Anglen, Lucinda J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S643 - S644
  • [32] Thioguanine in inflammatory bowel disease: Long-term efficacy and safety
    Ward, Mark G.
    Patel, Kamal V.
    Kariyawasam, Viraj C.
    Goel, Rishi
    Warner, Ben
    Elliott, Tim R.
    Blaker, Paul A.
    Irving, Peter M.
    Marinaki, Anthony M.
    Sanderson, Jeremy D.
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2017, 5 (04) : 563 - 570
  • [33] Infection Rates with Infliximab in Inflammatory Bowel Disease Compared to Rheumatologic Diseases: A Single Center Experience
    Sifuentes, Humberto
    Deepak, Parakkal
    Smith, Zachary
    Sridhar, Subbaramiah
    Yen, Eugene
    Ehrenpreis, Eli
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S662 - S662
  • [34] Efficacy and Safety of Infliximab in Older Inflammatory Bowel Disease Patients
    Lindenmeyer, Christina
    Moleski, Stephanie
    Whitsett, Maureen
    Kozuch, Patricia
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S509 - S509
  • [35] Efficacy and safety of infliximab and adalimumab in inflammatory bowel disease patients
    Kamal, Mahmoud E.
    Werida, Rehab H.
    Radwan, Mahasen A.
    Askar, Safaa R.
    Omran, Gamal A.
    El-Mohamdy, Marwa A.
    Hagag, Radwa S.
    INFLAMMOPHARMACOLOGY, 2024, 32 (05) : 3259 - 3269
  • [36] 10 Years of Infliximab: Long-Term Efficacy Outcome of 430 Crohn's Disease Patients in a Tertiary Referral Center
    Eshuis, Emma J.
    te Braake, Frans W.
    Ponsioen, Cyriel
    Bartelsman, Joep F.
    Bemelman, Willem
    Stokkers, Pieter
    GASTROENTEROLOGY, 2010, 138 (05) : S692 - S692
  • [37] Long-Term Efficacy and Safety of Golimumab for Ulcerative Colitis in a Pediatric Inflammatory Bowel Disease Center in Japan
    Tokita, Kazuhide
    Shimizu, Hirotaka
    Takeuchi, Ichiro
    Shimizu, Toshiaki
    Arai, Katsuhiro
    PEDIATRIC GASTROENTEROLOGY HEPATOLOGY & NUTRITION, 2022, 25 (06) : 461 - 472
  • [38] Infliximab in inflammatory bowel disease
    Papamichael, Konstantinos
    Lin, Steve
    Moore, Matthew
    Papaioannou, Garyfallia
    Sattler, Lindsey
    Cheifetz, Adam S.
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2019, 10
  • [39] Long Term Prognosis After Discontinuation of Infliximab in Patients With Inflammatory Bowel Disease in Clinical Remission
    Steenholdt, Casper
    Molazahi, Akbar
    Ainsworth, Mark A.
    Brynskov, Jorn
    Thomsen, Ole
    Seidelin, Jakob B.
    GASTROENTEROLOGY, 2012, 142 (05) : S204 - S204
  • [40] Long-Term Outcome of Infliximab Optimization for Overcoming Immunogenicity in Patients with Inflammatory Bowel Disease
    Papamichael, Konstantinos
    Vajravelu, Ravy K.
    Osterman, Mark T.
    Cheifetz, Adam S.
    DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (03) : 761 - 767
12345